OBJECTIVE: The aim of the study was to assess the longitudinal association between cardiovascular risk factors including albuminuria and other variables (e.g. awareness of hypertension, number of types of antihypertensive drugs, comorbidity), and health-related quality of life (HRQOL) in a large cohort of patients with hypertension, over a follow-up period of 5 years. METHODS: Nine thousand nine hundred and fifty-three participants of the ESTHER (Epidemiologische Studie zu Chancen der Verhütung, Früherkennung und optimierten Therapie chronischer Erkrankungen) study - a population-based cohort study of middle-aged and older adults aged 50-74 years at baseline - were recruited by general practitioners (GPs) in 2000-2002 and included in the follow-up (2005-2007). HRQOL at baseline and follow-up was measured using the Short-Form General Health Survey (SF-12). Mental component scores (MCS) and physical component scores (PCS) were calculated. Multiple linear regression models were used to determine longitudinal predictors of HRQOL at follow-up. RESULTS: Four thousand, two hundred and three patients with hypertension (98.2%) responded to the SF-12 both at baseline and after 5 years and were therefore included in the study. Smoking status, BMI, diabetes, macroalbuminuria, comorbid diseases, history of depression, and lower HRQOL at baseline predicted lower PCS at the 5-year follow-up. Lower MCS after 5 years was predicted by smoking status, dyslipidaemia, a reported history of depression, and HRQOL at baseline. No significant association was detected between awareness of hypertension and any HRQOL component score after 5 years. CONCLUSIONS: Macroalbuminuria and other variables related to increased cardiovascular risk have a negative impact on PCS. Suggestions of a link of treatment and awareness of hypertension with HRQOL from previous cross-sectional studies are not supported by our longitudinal findings.
OBJECTIVE: The aim of the study was to assess the longitudinal association between cardiovascular risk factors including albuminuria and other variables (e.g. awareness of hypertension, number of types of antihypertensive drugs, comorbidity), and health-related quality of life (HRQOL) in a large cohort of patients with hypertension, over a follow-up period of 5 years. METHODS: Nine thousand nine hundred and fifty-three participants of the ESTHER (Epidemiologische Studie zu Chancen der Verhütung, Früherkennung und optimierten Therapie chronischer Erkrankungen) study - a population-based cohort study of middle-aged and older adults aged 50-74 years at baseline - were recruited by general practitioners (GPs) in 2000-2002 and included in the follow-up (2005-2007). HRQOL at baseline and follow-up was measured using the Short-Form General Health Survey (SF-12). Mental component scores (MCS) and physical component scores (PCS) were calculated. Multiple linear regression models were used to determine longitudinal predictors of HRQOL at follow-up. RESULTS: Four thousand, two hundred and three patients with hypertension (98.2%) responded to the SF-12 both at baseline and after 5 years and were therefore included in the study. Smoking status, BMI, diabetes, macroalbuminuria, comorbid diseases, history of depression, and lower HRQOL at baseline predicted lower PCS at the 5-year follow-up. Lower MCS after 5 years was predicted by smoking status, dyslipidaemia, a reported history of depression, and HRQOL at baseline. No significant association was detected between awareness of hypertension and any HRQOL component score after 5 years. CONCLUSIONS: Macroalbuminuria and other variables related to increased cardiovascular risk have a negative impact on PCS. Suggestions of a link of treatment and awareness of hypertension with HRQOL from previous cross-sectional studies are not supported by our longitudinal findings.
Authors: Nigel P Stocks; David A González-Chica; Robyn L Woods; Jessica E Lockery; Rory S J Wolfe; Anne M Murray; Brenda Kirpach; Raj C Shah; Mark R Nelson; Christopher M Reid; Michael E Ernst; John J McNeil Journal: Qual Life Res Date: 2018-11-08 Impact factor: 4.147
Authors: Samah W Al-Jabi; Sa'ed H Zyoud; Waleed M Sweileh; Aysha H Wildali; Hanan M Saleem; Hayat A Aysa; Mohammad A Badwan; Rahmat Awang Journal: Health Expect Date: 2014-12-07 Impact factor: 3.377
Authors: M Muller; H M Jochemsen; F L J Visseren; A M Grool; L J Launer; Y van der Graaf; M I Geerlings Journal: J Intern Med Date: 2013-04-11 Impact factor: 8.989
Authors: Pedro Marques da Silva; Uwe Haag; Julian F Guest; John E Brazier; Marco Soro Journal: Health Qual Life Outcomes Date: 2015-02-21 Impact factor: 3.186
Authors: Jacqueline Müller-Nordhorn; Rebecca Muckelbauer; Heike Englert; Ulrike Grittner; Hendrike Berger; Frank Sonntag; Heinz Völler; Christof Prugger; Karl Wegscheider; Hugo A Katus; Stefan N Willich Journal: PLoS One Date: 2014-03-26 Impact factor: 3.240